Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Medipal Holdings ( (JP:7459) ) has shared an update.
Medipal Holdings Corporation has announced a strategic initiative to enhance its management approach by focusing on the cost of capital and stock price. The company has set a target of achieving a 9% ROE by 2027, recognizing the need to improve its PBR, which has been below 1.0 for the past five years. To achieve these goals, Medipal plans to strengthen profitability, optimize resource allocation, and enhance its human capital strategy. Additionally, the company aims to improve its investor relations and information dissemination to individual investors.
The most recent analyst rating on (JP:7459) stock is a Hold with a Yen2620.00 price target. To see the full list of analyst forecasts on Medipal Holdings stock, see the JP:7459 Stock Forecast page.
More about Medipal Holdings
Medipal Holdings Corporation operates in the healthcare and pharmaceutical distribution industry, focusing on the distribution of pharmaceuticals, health and beauty products, and medical devices. The company is listed on the Tokyo Stock Exchange and is committed to innovation and enhancing shareholder value.
Average Trading Volume: 388,684
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen456.9B
For detailed information about 7459 stock, go to TipRanks’ Stock Analysis page.